Old Web
Effect of combination inhibition of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGF-R) on ovarian cancer cell lines
2006
13112 Background: Bevacizumab, a VEGF inhibitor, and cetuximab, an EGF-R inhibitor, have shown promising results in the treatment of solid tumors. The combination of these two antibodies and combin...
Keywords:
- Vascular endothelial growth inhibitor
- Co-receptor
- Vascular endothelial growth factor C
- Cancer research
- Growth factor receptor inhibitor
- Fibroblast growth factor receptor 2
- Vascular endothelial growth factor
- Vascular endothelial growth factor A
- Biology
- Vascular endothelial growth factor B
- Medicine
- Pathology
- Epidermal growth factor receptor
- Cetuximab
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI